Skip to main content
CONTEC MEDICAL SYSTEMS CO., LTD. logo

CONTEC MEDICAL SYSTEMS CO., LTD. — Investor Relations & Filings

Ticker · 300869 ISIN · CNE1000047F0 LEI · 6556007SL3V6YKCWVA55 Shenzhen Stock Exchange Manufacturing
Filings indexed 789 across all filing types
Latest filing 2022-04-26 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300869

About CONTEC MEDICAL SYSTEMS CO., LTD.

https://www.contecmed.com.cn

CONTEC Medical Systems Co., Ltd. focuses on the research, development, manufacturing, and distribution of medical electronic instruments. The product portfolio encompasses a wide range of diagnostic and monitoring solutions, including pulse oximeters, blood pressure monitors, electrocardiographs, ultrasound equipment, and multi-parameter patient monitors. Additionally, the company provides specialized devices such as fetal monitors, sleep apnea screening systems, and biochemical analyzers. By leveraging integrated research and large-scale production facilities, the organization delivers medical technology designed for clinical, hospital, and home healthcare environments. The company emphasizes technical innovation and adheres to international quality standards to ensure the precision and reliability of its medical hardware and software solutions.

Recent filings

Filing Released Lang Actions
2021年年度报告
Regulatory Filings
2022-04-26 Chinese
关于修订公司章程及部分制度的公告
Governance Information Classification · 95% confidence The document is a detailed announcement regarding revisions to the company's articles of association (公司章程) and related governance rules, including shareholders' meeting rules (股东大会议事规则) and board meeting rules (董事会议事规则). It includes extensive legal and procedural text about the powers and responsibilities of the shareholders' meeting, board of directors, and other governance structures. The document does not contain financial statements, earnings data, or audit opinions. It is not a report of financial results or an audit report, but rather a governance-related announcement about internal rules and procedures. Therefore, it fits best under the category of Governance Information (CGR). The document length and detail confirm it is the actual governance document, not just an announcement of publication or a brief notice.
2022-04-26 Chinese
康泰医学2021年度内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled as an "内部控制自我评价报告" which translates to "Internal Control Self-Evaluation Report" for the year ending December 31, 2021. It discusses the company's internal control systems, evaluation scope, standards for identifying control deficiencies, and the conclusion that no major deficiencies exist. The document is detailed and contains substantive information about internal control evaluation, which is typical of an Audit Report or Information related to internal controls rather than a full Annual Report or other filings. It is not a brief announcement or a certification letter but a comprehensive internal control evaluation report. Therefore, it fits best under the category of Audit Report / Information (AR). FY 2021
2022-04-26 Chinese
独立董事2021年度述职报告(彭勇)
Management Reports Classification · 95% confidence The document is a detailed annual report by an independent director of 康泰医学系统(秦皇岛)股份有限公司 for the year 2021. It includes descriptions of attendance at board and shareholder meetings, independent opinions on various company matters, committee work, on-site investigations, and efforts to protect investor rights. The content is a comprehensive narrative of the director's duties and activities over the year, rather than a brief announcement or a certification. The document length is 3313 characters, which is relatively short but contains substantive content about the director's annual duties and opinions, fitting the nature of a Management Report rather than a simple announcement or regulatory filing. It does not contain financial statements or quarterly data, so it is not an Annual Report (10-K) or Interim Report (IR). It is not a Board/Management change announcement (MANG) or a proxy solicitation. The focus on the independent director's annual duties and opinions aligns best with Management Reports (MDA).
2022-04-26 Chinese
独立董事提名人声明
Board/Management Information Classification · 95% confidence The document is a public statement from the board nominating an independent director candidate, detailing the candidate's qualifications and compliance with various regulatory requirements. It does not contain financial data, earnings, or report content. It is an announcement related to board/management changes, specifically the nomination of a board member. Therefore, it fits the category of Board/Management Information (MANG). The document length and content support this classification with high confidence.
2022-04-26 Chinese
《内幕信息知情人登记及报备制度》
Regulatory Filings Classification · 95% confidence The document is a detailed internal policy and procedural manual regarding the registration and reporting system for insiders with knowledge of material non-public information (insider information) at 康泰医学系统(秦皇岛)股份有限公司. It outlines definitions, scope, responsibilities, confidentiality, and reporting requirements related to insider information. There are no financial statements, earnings data, or direct financial results presented. The document is regulatory and compliance-focused, detailing internal governance and control procedures rather than reporting financial performance or management changes. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is not a simple announcement or certification but a substantive internal governance document. The closest fitting category is Regulatory Filings (RNS), which covers compliance documents and miscellaneous filings that do not fit other categories. Confidence is high given the document's nature and content.
2022-04-26 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.